Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

Recruiting

IloperidoneSafety and Tolerability of Open-Labeled Iloperidone in Adolescents

Sponsor:

Vanda Pharmaceuticals

Code:

NCT05648591

Conditions

Schizophrenia

Bipolar I Disorder

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Iloperidone

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Vanda Pharmaceuticals on 2025-03-04.